QKS [2021] NSWCATGD 37

NSW Civil and Administrative Tribunal New South Wales Medium Neutral Citation: QKS [2021] NSWCATGD 37 Hearing dates: 24 June 2021 Date of orders: 24 June 2021 Decision date: 24 June 2021 Jurisdiction: Guardianship Division Before: R H Booby, Senior Member (Legal) Dr B McPhee, Senior Member (Professional) F N Given, General Member (Community) Decision: The Tribunal consents to the following special medical treatment being provided to QKS: Administration of up to 300mg daily of Cyproterone Acetate (Androcur) and any necessary treatment that would normally be provided in association with or directly consequent upon the above treatment. This consent is effective for a period of 12 month(s) from the date of this order. This consent is effective even though QKS objects to the treatment. Catchwords: CONSENT TO MEDICAL TREATMENT – application for consent to special medical treatment – androgen reducing medication for the purpose of behavioural control – Androcur (Cyproterone Acetate) – patient with an intellectual disability and paedophilic tendencies – patient exhibits disinhibited sexualised behaviour – patient not able to provide own consent – whether the treatment is the most appropriate form of treatment to promote health and well-being – consent given. Legislation Cited: Guardianship Act 1987 (NSW), ss 33(2), 42(2); Pt 5 Guardianship Regulations 2016 (NSW), cl 14(b) Cases Cited: None cited. Texts Cited: None cited. Category: Principal judgment Parties: 002: Consent to Special Medical Treatment